Guidelines for the diagnosis and management of von Willebrand disease in Italy.
about
Von Willebrand disease: an overviewLIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.von Willebrand disease type 2B must be always considered in the differential diagnosis of genetic thrombocytopenias with giant platelets.The role of von Willebrand factor in hemorrhagic and thrombotic disorders.Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease.Cost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context.Treatment of patients with von Willebrand disease.Utility of a high VWF: FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice.Clinical diagnosis of von Willebrand disease.Current understanding of von Willebrand's disease in women - some answers, more questions.Diagnostic approach to inherited bleeding disorders.Management of inherited von Willebrand disease in 2007.von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).Prophylaxis of bleeding episodes in patients with von Willebrand's disease.Evidence-based recommendations on the treatment of von Willebrand disease in Italy.The management of patients with congenital von Willebrand disease during surgery or other invasive procedures: focus on antihemophilic factor/von Willebrand factor complex.When von Willebrand disease comes into age - a matter of change?Diagnosis and management of women with bleeding disorders--international guidelines and consensus from an international expert panel.Current management of patients with severe von Willebrand disease type 3: a 2012 update.An update on type 2B von Willebrand disease.A diagnostic approach to mild bleeding disorders.Current and emerging approaches for assessing von Willebrand disease in 2016.Von Willebrand factor (Vonvendi®): the first recombinant product licensed for the treatment of von Willebrand disease.Von Willebrand disease in the emergency department.Hematological evaluation of acquired von Willebrand syndrome before oral surgery: Management of an unusual case.Phenotypic correction of von Willebrand disease type 3 blood-derived endothelial cells with lentiviral vectors expressing von Willebrand factor.Efficacy of Octocog Alfa (Advate) in a Child with Type 3 von Willebrand Disease and AlloantibodiesClinical and laboratory versus molecular markers for a correct classification of von Willebrand disease.Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease.Evaluation of von Willebrand factor during pregnancy, lactation and oestrous cycle in bitches affected and unaffected by von Willebrand disease.A comparative in vitro evaluation of six von Willebrand factor concentrates.A single-centre study of haemostatic outcomes of joint replacement in von Willebrand disease and control patients and an analysis of the literature.Efficacy of tranexamic acid for the prevention of bleeding in patients with von Willebrand disease and Glanzmann thrombasthenia: a controlled, before and after trial.Acquired von Willebrand's disease associated with gastrointestinal angiodysplasia: a case report.The 80th anniversary of von Willebrand's disease: history, management and research.von Willebrand disease: a clinical and laboratory study of sixty-five patients.Repeated infusions of VWF/FVIII concentrate: impact of VWF:FVIII ratio on FVIII trough and peak levels in a rabbit model.Pharmacokinetics of VWF/FVIII concentrates is a very intricate matter.Type 3 von Willebrand disease: assessment of complications and approaches to treatment -- results of a patient and Hemophilia Treatment Center Survey in the United States.Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination.
P2860
Q28742241-918271D7-7447-41A4-8ACB-D837F585563DQ30819316-92C12949-161E-4D3E-A3DB-26EEEB3B719FQ33371210-DA90C89E-B490-4AAB-B922-910BD34769B0Q33374578-6E389E0B-F281-4B8B-A664-F2BA685D1C3BQ34476143-AA80DF41-85B6-43BA-AF45-20F6DB2535A6Q34758065-88675C62-1C9F-4ABC-8A68-C955EAEF9CB7Q35683876-DD925DE7-74AD-486E-88DA-2B57C35569BDQ35846930-0F30DBFF-7ECB-4117-8136-A7440F561457Q35915740-C9F1ACD8-B4D1-45F1-9625-5CA764FEA4FFQ36473099-91EC53E6-B481-422A-8811-2BFEA3A949EDQ36715734-845746A8-8BE2-459B-8AE5-F3391DBA19CCQ36911419-42147AFD-3422-4587-B8EF-2431A1DAFDA0Q37100261-73604CA2-BA2D-4FE6-A2B4-5FE601D15A4BQ37119655-08A30D8F-892D-4FCA-B512-DDDF0372A19EQ37209112-574EB406-B154-4ABD-8B75-D7ECBB76A664Q37586863-DC566464-1042-4441-8DC1-BEBD5B827AA0Q37854842-91BD2CF5-D66C-473F-A039-4585533422CBQ37892647-1AEB476C-09D0-4CD8-B578-BB7595EDE150Q38020749-20DD7E22-8267-45C7-8EA7-DCB107254163Q38187477-AC5B0D05-39FF-42E3-A0E8-FC9358E16A9BQ38840603-3D13D49A-488D-46F5-9422-E5FFB5CF4681Q38900004-A824A5E4-1F2C-47F7-8855-3D4D61726FABQ38900471-19966BDE-2A15-41D3-ACCE-530CE598263DQ40329972-ABEA9C12-94C5-40F9-9E89-606B31ECADE9Q42143381-D844A7D6-CE2C-431D-B584-B3AE06123091Q42193828-09AC8E8E-45AA-4D33-96EF-F0F3589B9465Q42364688-9EB52FDC-3688-4E8A-8558-3C87B5D7A735Q43137286-867A727A-20AC-40CF-B791-DCE4ACCCFCB9Q44320698-405656F0-B0B2-4C8A-87D2-76969895035DQ44326387-A16EC6E1-E418-4BF5-97D6-1D8BCDC46DB1Q44845858-AB79F22A-8F5A-4484-A893-AAB6A6923C6BQ45856018-B51471D8-8E6D-4287-B63E-C6BA040AC19EQ45856961-7028DC21-1EB0-4B90-BAB4-1E5DE39BF9F7Q45859690-56DC648F-3BFD-4E2C-856F-2C548BAA40C1Q45863536-1D45844A-4B4D-46B3-B097-E0FC938E5707Q45870652-408A295F-4E95-41CD-B83B-90C272B4E3C5Q45871507-BAD56D9E-70B7-4A5F-8F46-C3D99F02105BQ45874399-8063F6ED-EC05-4794-B395-BEC464F328D6Q45876357-DF797E14-C748-4153-8AC7-2BA0C862D37FQ45877995-620AB869-F719-4175-B673-20B504FEBE8D
P2860
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
@en
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
@nl
type
label
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
@en
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
@nl
prefLabel
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
@en
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
@nl
P2093
P2860
P1433
P1476
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
@en
P2093
A B Federici
G Castaman
Italian Association of Hemophilia Centers (AICE)
P M Mannucci
P2860
P304
P356
10.1046/J.1365-2516.2002.00672.X
P577
2002-09-01T00:00:00Z